中文
|
English
Search
Home
About Us
Return
About Kylonova
About siRNA
Drug Delivery Platform
Return
Nano-Lipid particle delivery platform ( NPDP)
Multivalent import platform(MVIP)
Lipid coupling delivery platform(LCDP)
R&D
Return
Kylo-01
Kylo-02
Kylo-03
Kylo-04
Product
Return
Compounds of delivery vehicle
Terminus modifiers
Customized Service
Our Advantage
News
Return
Company News
Industry Dynamics
Service Center
Return
Contact Us
Online Message
Join Us
Home
About Us
Return
About Kylonova
About siRNA
Drug Delivery Platform
Return
Nano-Lipid particle delivery platform ( NPDP)
Multivalent import platform(MVIP)
Lipid coupling delivery platform(LCDP)
R&D
Return
Kylo-01
Kylo-02
Kylo-03
Kylo-04
Product
Return
Compounds of delivery vehicle
Terminus modifiers
Customized Service
Our Advantage
News
Return
Company News
Industry Dynamics
Service Center
Return
Contact Us
Online Message
Join Us
AsiaTIDES 2018
Column :Company News
Time :2018-12-04
Previous :
Conventional dosage forms and systemic administration of siRNA show therapeutic effects in animals
Next :
TIDES 2018